In-Person Access Only | 1.75 CME Credits
Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $25 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com
The Cancer Updates Conference will feature educational activities designed to meet the needs of medical oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of hematologic malignancies, as well as lung, GI, GU and breast cancers. Each program agenda includes presentations that distill the most clinically relevant information for application in community oncology settings. This dinner program will be hosted as an in-person event only.
Conference Agenda
Thursday, October 29, 2026
5:00 PM
Networking and Cocktails
5:30 PM
Welcome and Opening Remarks
Adam Brufsky, MD | UPMC Hillman Cancer Center
5:35 PM
Updates in Lung Cancers
5:55 PM
Updates in Gastrointestinal Cancers
Dulabh Monga, MD | Allegheny Health Network
6:15 PM
Dinner and Exhibits
6:30 PM
Non CME Session
7:15 PM
Updates in Breast Cancers
Adam Brufsky, MD | UPMC Hillman Cancer Center
7:35 PM
Updates in Genitourinary Cancers
7:55 PM
Updates in Hematologic Malignancies
Salman Fazal, MD | UPMC Hillman Cancer Center
8:15 PM
ADJOURN
Agenda Subject To Change. All times are EST.
-
Review recent clinical advances in the treatment of gastrointestinal (GI) and breast cancers, with a focus on the most relevant data from recent studies and clinical trials.
Evaluate the role of emerging therapies in GI and breast cancer treatment, including new medications, targeted therapies, and immunotherapies.
Apply evidence-based strategies to improve patient outcomes in community oncology settings, focusing on the integration of new treatment approaches.
Assess and manage side effects and toxicities associated with current and emerging therapies in GI and breast cancer patients.
Discuss multidisciplinary care approaches that enhance collaboration between oncologists, pharmacists, nurses, and advanced practitioners in treating GI and breast cancers.
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 1.75 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 1.75 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources